Study S000721

Metabolic Optimization and Training InterVentions for Aging and Type 2 Diabetes to Enhance Cognition: the MOTIVATE Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07485062
Acronym: MOTIVATE
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: SINGLE
Status: NOT_YET_RECRUITING
Enrollment: 164
Start: 2026-09-01
Primary completion: 2029-05-01
Lead sponsor: Western University, Canada
Conditions: Type 2 Diabetes; Cognitive Decline in Older Adults
Interventions: DRUG:semaglutide; BEHAVIORAL:Moderate-Intensity Resistance Exercise; BEHAVIORAL:Balance and Tone (BAT) Exercise
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: OTHER_GRANT:528313

Registered primary outcomes

Trail Making Test (TMT) Part A and B [Baseline (Week 0), Midpoint (Week 16), Endpoint (Week 32)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.